ArticleCell death & disease2019

Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma.

Jacopo Gavini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.